Erratum: Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers (Cancer Res (2010) 70: 14 (5695–5705) DOI: 10.1158/0008-5472.CAN-10-0392);Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers

Cancer Research

Volumn 70, Issue 14, 2010, Pages 5695-5705

  Li, Yan ^a   Nie, Chang Jun ^a   Hu, Liang ^b   Qin, Yanru ^c   Liu, Hai Bo ^a   Zeng, Ting Ting ^a   Chen, Leilei ^b   Fu, Li ^b   Deng, Wen ^b   Chen, Shu Peng ^a   Jia, Wei Hua ^a   Zhang, Chunyu ^a,d   Xie, Dan ^a   Guan, Xin Yuan ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CARCINOGENICITY; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA DAMAGE; EMBRYONIC STEM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; NM23H1 GENE; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SEI1 GENE; SET GENE; SISTER CHROMATID EXCHANGE; UPREGULATION; WESTERN BLOTTING;

EID: 77955029578     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-22-1137     Document Type: Erratum

References (37)

1. Tirkkonen M, Tanner M, Karhu R, et al. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998; 21:177-84.
2. Gronwald J, Jauch A, Cybulski C, et al. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 2005;114:230-6.
3. Yen CC, Chen YJ, Lu KH, et al. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction. Int J Oncol 2003;23:871-81.
4. Carneiro A, Isinger A, Karlsson A, et al. Prognostic impact of arraybased genomic profiles in esophageal squamous cell cancer. BMC Cancer 2008;8:98.
5. Thompson FH, Nelson MA, Trent JM, et al. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet 1996;87:55-62.
6. Sham JS, Tang TC, Fang Y, et al. Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet Cytogenet 2002;133:39-44.
7. Choi JS, Zheng LT, Ha E, et al. Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas. Lung 2006;184:355-62.
8. Curtis LJ, Li Y, Gerbault-Seureau M, et al. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 1998;53:42-55.
9. Tang TC, Sham JS, Xie D, et al. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines. Cancer Res 2002;62:7157-61.
10. SEI-1. Genes Dev 1999;13: 3027-33.
11. Hsu SI, Yang CM, Sim KG, et al. TRIP-Br: a novel family of PHD zinc finger- and bromodomain- interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J 2001;20:2273-85.
12. Li J, Melvin WS, Tsai MD, et al. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentrationdependent manner. Biochemistry 2004;43:4394-9.
13. Hong SW, Kim CJ, Park WS, et al. p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies. Cancer Res 2009;69:741-6.
14. Tang DJ, Hu L, Xie D, et al. Oncogenic transformation by SEI-1 is associated with chromosomal instability. Cancer Res 2005;65: 6504-8.
15. Carvajal D, Tovar C, Yang H, et al. Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors. Cancer Res 2005;65:1918-24.
16. Fan Z, Beresford PJ, Oh DY, et al. Tumor suppressor NM23H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112:659-72.
17. Chowdhury D, Beresford PJ, Zhu P, et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 2006;23: 133-42.
18. Zhao T, Zhang H, Guo Y, et al. Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells. Cell Death Differ 2007;14:489-99.
19. Ma D, Xing Z, Liu B, et al. NM23H1 and NM23-2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter. J Biol Chem 2002;277:1560-7.
20. Shimada Y, Imamura M, Wagata T, et al. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992;69:277-84.
21. Fu L, Qin YR, Xie D, et al. Characterization of a novel tumor-suppressor gene PLC δ 1 at 3p22 in esophageal squamous cell carcinoma. Cancer Res 2007;67:10720-6.
22. Karpf AR, Matsui S. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 2005;65:8635-9.
23. Guan XY, Sham JS, Tang TC, et al. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res 2001;61:3806-9.
24. Fu L, Qin YR, Xie D, et al. Identification of α-actin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. Cancer 2007;110:2672-81.
25. Wang Y, Wu MC, Sham JS, et al. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 2002;95:2346-52.
26. Deen DF, Kendall LE, Marton LJ, et al. Prediction of human tumor cell chemosensitivity using the sister chromatid exchange assay. Cancer Res 1986;46:1599-602.
27. Ford JH, Schultz CJ, Correll AT. Chromosome elimination in micronuclei: a common cause of hypoploidy. Am J Hum Genet 1988;43: 733-40.
28. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992;71:543-6.
29. Wang X, Zhou YX, Qiao W, et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 2006;25:7148-58.
30. Sugihara E, Kanai M, Matsui A, et al. Enhanced expression of MYCN leads to centrosome hyperamplification after DNA damage in neuroblastoma cells. Oncogene 2004;23:1005-9.
31. Von Lindern M, Breeme D, van Baal S, et al. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer 1992;5:227-34.
32. Lacombe ML, Milon L, Munier A, et al. The human Nm23/ nucleoside diphosphate kinases. J Bioenerg Biomembr 2000; 32:247-58.
33. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-4.
34. Leone A, Flatow U, King CR, et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991;65:25-35.
35. Negroni A, Venturelli D, Tanno B, et al. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Cell Death Differ 2000;7:843-50.
36. Kaetzel DM, Zhang Q, Yang M, et al. Potential roles of 3′-5′ exonuclease activity of NM23H1 in DNA repair and malignant progression. J Bioenerg Biomembr 2006;38:163-7.
37. Ma D, McCorkle JR, Kaetzel DM. The metastasis suppressor NM23H1 possesses 3′-5′ exonuclease activity. J Biol Chem 2004; 279:18073-84.